These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 2790791

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
    Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Estes L.
    Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
    [Abstract] [Full Text] [Related]

  • 26. Synergistic effect of recombinant interleukin-2 on the inhibition of growth of adenocarcinoma 755 by mitomycin.
    Ligo M, Sakurai M, Saijo N, Hoshi A.
    Cancer Treat Rep; 1987 Jun; 71(6):567-70. PubMed ID: 3495334
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T, Blancher A, Calvas P, Neulat-Duga I, Delsol G.
    Ann Pathol; 1987 Jun; 7(1):1-8. PubMed ID: 3040026
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H, Yamaguchi Y, Kadoyama C, Sato N, Fujisawa T.
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [Abstract] [Full Text] [Related]

  • 31. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA, Schreiber GJ, Cosand WL, Raff HV.
    Cancer Res; 1993 Jun 01; 53(11):2560-5. PubMed ID: 8495420
    [Abstract] [Full Text] [Related]

  • 32. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK, Long BH, Chakrabarty S, Brattain DE, Brattain MG.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [Abstract] [Full Text] [Related]

  • 33. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
    Nishiyama M, Kim R, Saeki T, Takagami S, Kirihara Y, Jinushi K, Toge T, Niimoto M, Hattori T.
    Gan To Kagaku Ryoho; 1988 Nov 01; 15(11):3133-7. PubMed ID: 3142368
    [Abstract] [Full Text] [Related]

  • 34. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Florczyk AP, Huftalen JB, Catino JJ.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [Abstract] [Full Text] [Related]

  • 35. [Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
    Kubota T, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):938-44. PubMed ID: 3083789
    [Abstract] [Full Text] [Related]

  • 36. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 37. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
    Zhu XK, Guan J, Tachibana Y, Bastow KF, Cho SJ, Cheng HH, Cheng YC, Gurwith M, Lee KH.
    J Med Chem; 1999 Jul 01; 42(13):2441-6. PubMed ID: 10395485
    [Abstract] [Full Text] [Related]

  • 38. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
    Sun X, Wong JR, Song K, Hu J, Garlid KD, Chen LB.
    Cancer Res; 1994 Mar 15; 54(6):1465-71. PubMed ID: 8137249
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.
    Clin Cancer Res; 2000 May 15; 6(5):2075-86. PubMed ID: 10815935
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.